Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
GeneDx HoldingsWGS | Open-market sale | 06/16 | 06/18 | 10,501 sh3 trades | $60.76avg. | $638,092.06 | −9.1% | |
GeneDx HoldingsWGS | Open-market sale | 06/16 | 06/18 | 3,729 sh3 trades | $60.76avg. | $226,592.48 | −8.5% | |
GeneDx HoldingsWGS | Open-market sale | 06/09 | 06/11 | 3,639 sh | $53.77 | $195,669.03 | −3.6% | |
Feeley KevinCFO | GeneDx HoldingsWGS | Open-market sale | 06/09 | 06/11 | 1,266 sh | $53.77 | $68,072.82 | −3.4% |
GeneDx HoldingsWGS | Open-market buy | 06/04–06/05 | 06/08 | 200,000 sh2 trades | $55.55avg. | $11,109,000 | +5.7% | |
GeneDx HoldingsWGS | Open-market buy | 06/04–06/05 | 06/08 | 200,000 sh2 trades | $55.55avg. | $11,109,000 | +5.7% | |
GeneDx HoldingsWGS | Open-market buy | 06/04–06/05 | 06/08 | 200,000 sh2 trades | $55.55avg. | $11,109,000 | +5.7% | |
GeneDx HoldingsWGS | Open-market buy | 06/04–06/05 | 06/08 | 200,000 sh2 trades | $55.55avg. | $11,109,000 | +5.7% | |
Feeley KevinCFO | GeneDx HoldingsWGS | Open-market sale | 06/01 | 06/03 | 369 sh | $51.74 | $19,092.06 | −1.0% |
GeneDx HoldingsWGS | Open-market buy | 05/18–05/20 | 05/20 | 500,000 sh3 trades | $42.92avg. | $21,460,650 | +16.6% | |
GeneDx HoldingsWGS | Open-market buy | 05/18–05/20 | 05/20 | 500,000 sh3 trades | $42.92avg. | $21,460,650 | +16.6% | |
GeneDx HoldingsWGS | Open-market buy | 05/18–05/20 | 05/20 | 500,000 sh3 trades | $42.92avg. | $21,460,650 | +16.6% | |
GeneDx HoldingsWGS | Open-market buy | 05/18–05/20 | 05/20 | 500,000 sh3 trades | $42.92avg. | $21,460,650 | +16.6% | |
GeneDx HoldingsWGS | Open-market buy | 05/13–05/15 | 05/15 | 351,273 sh6 trades | $39.19avg. | $13,765,344.69 | +7.9% | |
Director | GeneDx HoldingsWGS | Open-market buy | 05/13–05/15 | 05/15 | 351,273 sh6 trades | $39.19avg. | $13,765,344.69 | +7.9% |
GeneDx HoldingsWGS | Open-market buy | 05/07–05/11 | 05/11 | 1,205,147 sh13 trades | $38.84avg. | $46,806,729.12 | +37.3% | |
Director | GeneDx HoldingsWGS | Open-market buy | 05/07–05/11 | 05/11 | 1,205,147 sh13 trades | $38.84avg. | $46,806,729.12 | +37.3% |
GeneDx HoldingsWGS | Open-market sale | 04/29 | 05/01 | 2,172 sh2 trades | $65.19avg. | $141,594.96 | −2.3% | |
Feeley KevinCFO | GeneDx HoldingsWGS | Open-market sale | 04/29 | 05/01 | 392 sh | $65.19 | $25,554.48 | −1.1% |
GeneDx HoldingsWGS | Open-market sale | 03/26 | 03/30 | 46,933 sh5 trades | $63.17avg. | $2,964,793.01 | −33.9% |
